diff --git a/Qualification/Input/Content/Qualification_DDI_CYP3A4_network_description.md b/Qualification/Input/Content/Qualification_DDI_CYP3A4_network_description.md
index 9003926..3e1b9e4 100644
--- a/Qualification/Input/Content/Qualification_DDI_CYP3A4_network_description.md
+++ b/Qualification/Input/Content/Qualification_DDI_CYP3A4_network_description.md
@@ -5,19 +5,19 @@ The following perpetrator compounds were selected:
 - **Rifampicin** (strong CYP3A4 inducer)
   Model snapshot and evaluation plan (*release* **v1.2**): https://github.com/Open-Systems-Pharmacology/Rifampicin-Model/releases/tag/v1.2
 - **Carbamazepine** (moderate CYP3A4 inducer)
-  Model snapshot and evaluation plan (*release* **v1.2**): [Release Model snapshot and evaluation plan version 1.2 · Open-Systems-Pharmacology/Carbamazepine-Model · GitHub](https://github.com/Open-Systems-Pharmacology/Carbamazepine-Model/releases/tag/v1.2)
+  Model snapshot and evaluation plan (*release* **v1.3**): [https://github.com/Open-Systems-Pharmacology/Carbamazepine-Model/releases/tag/v1.3](https://github.com/Open-Systems-Pharmacology/Carbamazepine-Model/releases/tag/v1.3)
 - **Efavirenz** (moderate CYP3A4 inducer)
   Model snapshot and evaluation plan (*release* **v1.1**): https://github.com/Open-Systems-Pharmacology/Efavirenz-Model/releases/tag/v1.1
 - **Cimetidine** (weak CYP3A4 inhibitor)
-  Model snapshot and evaluation plan (*release* **v1.1**): https://github.com/Open-Systems-Pharmacology/Cimetidine-Model/releases/tag/v1.1
+  Model snapshot and evaluation plan (*release* **v1.2**): https://github.com/Open-Systems-Pharmacology/Cimetidine-Model/releases/tag/v1.2
 - **Fluvoxamine** (weak/moderate CYP3A4 inhibitor)
-  Model snapshot and evaluation plan (*release* **v1.1**): https://github.com/Open-Systems-Pharmacology/Fluvoxamine-Model/releases/tag/v1.1
+  Model snapshot and evaluation plan (*release* **v1.2**): https://github.com/Open-Systems-Pharmacology/Fluvoxamine-Model/releases/tag/v1.2
 - **Verapamil** (moderate CYP3A4 inhibitor)
   Model snapshot and evaluation plan (*release* **v1.2**): https://github.com/Open-Systems-Pharmacology/Verapamil-Model/releases/tag/v1.2
 - **Fluconazole** (moderate CYP3A4 inhibitor)
   Model snapshot and evaluation plan (*release* **v1.0**): https://github.com/Open-Systems-Pharmacology/Fluconazole-Model/releases/tag/v1.0
 - **Erythromycin** (moderate CYP3A4 inhibitor)
-  Model snapshot and evaluation plan (*release* **v1.2**): https://github.com/Open-Systems-Pharmacology/Erythromycin-Model/releases/tag/v1.2
+  Model snapshot and evaluation plan (*release* **v1.3**): https://github.com/Open-Systems-Pharmacology/Erythromycin-Model/releases/tag/v1.3
 - **Clarithromycin** (strong CYP3A4 inhibitor)
   Model snapshot and evaluation plan (*release* **v1.2**): https://github.com/Open-Systems-Pharmacology/Clarithromycin-Model/releases/tag/v1.2
 - **Itraconazole** including metabolites (strong CYP3A4 inhibitor)